MarketInOut Stock Screener Log In | Sign Up
 

GeneDx Holdings Corp

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
GeneDx Holdings Corp stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,994.68 mln
Float28.90 mln
Earnings Date11/03/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.7
Likely reliable

1-Year Forecast

93.50
Transformational upside

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.69
Moderate leverage

Pre-Tax Margin

-23%
Deeply loss-making

Business Description

GeneDx helps doctors identify rare and inherited diseases by analyzing patients' genetic information. The company specializes in testing children and individuals with uncommon conditions, using advanced sequencing technology to examine their complete genetic makeup. It also builds artificial intelligence tools that help medical professionals make sense of complex genetic data and produce clear clinical reports.

Key Fundamentals

EPS-3.63
ROE-38.65
RPS15.55
ROIC-17.89
ROA-21.14
Interest Cover-20.31
EBITDA, mln-76.43
EV / EBITDA-28.58
EV / EBIT-21.15
Revenue, mln454
EV / Revenue4.81

Quote Details

Last 56.15
Change -10.99 (-16.37%)
Open 67.20
Volume 2,545,747
Turnover 142,943,696
Average Volume 789,191

Financial Ratios

Pre-Tax Profit Margin-23
Leverage Ratio1.97
Current Ratio3.30
Price / Book8.83
Price / Tangible Book21.26
Debt / Equity0.69
Price / Sales4.62

Financial Strength

Altman Z-Score2.15
Piotroski F-Score 5 / 9
Beneish M-Score-2.7
1-Year Target Price93.50
Short Ratio7.71
Short % of Float36.11

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.73% 7 / 100   
1 Month -36.54% 8 / 100   
2 Months -7.42% 36 / 100   
6 Months -18.07% 27 / 100   
1 Year -53.6% 17 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog